SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (4325)6/24/1998 1:06:00 PM
From: Michael Burry  Read Replies (3) | Respond to of 78688
 
Congrats Paul. There goes Methode, up significantly on already-triple volume on no news. Of course it's still on my "buy soon" list - other than Ron's observations, I couldn't find a reason to invest quickly enough. Meanwhile, the stocks in my portfolio have taken turns hemorrhaging, and it's awfully hard to figure which ones are at risk cuz they all seem so darn cheap already. With an average PE of 9.6 and an avg yield of 2.3%, PSO is my high-PE play <g>. I still like all the stocks in my sealpoint portfolio, which is up-to-date except for BHP, which I sold (at its short-term bottom) to make room for PSO. They've all been brought up here before, but especially New Holland and Deswell seem inexplicably cheap. The Deswell thread here is the best source of info on the company anywhere, and Ron's recent post about his talk with the CEO may shed some light on the weakness, which is overdone IMO. As I've said before, I've talked with the CEO as well, and he is very seriously and successfully running the company. He seems to regard the stock market volatility as extraneous and somewhat humorous. Yes, the stock's down over 30% in recent months, but last time this happened, he told me "long-term investors should regard it as a buying opportunity." The dividend isn't quarterly, but it has been generous. New Holland stock is no doubt suffering due to the emerging market weakness and the threat of a world recession, but and as with Deswell there's a decent dividend while you wait. And that low PE is real - the company is flush with true earnings and cash-generating ability, even now in the face of the last 9 months of emerging market turmoil. Jim Clarke knows the company better than me (I believe he's had access to management in the past), so maybe he can comment on the sub-$20 price.

Mike